Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sater

Showing results (381-390 of 438) with videos related to

Pageof 44
Sort By:
Clinical Therapeutics|July 22, 2008
Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 microg QOD in patients with relapsing-remitting multiple sclerosis: a multicenter, randomized, double-blind, parallel-group pilot studyBarrie J Hurwitz, Douglas Jeffery, Barry Arnason, et al.
JCO Global Oncology|February 8, 2020
High-Cost Cancer Treatment Across Borders in Conflict Zones: Experience of Iraqi Patients in LebanonMac Skelton, Raafat Alameddine, Omran Saifi, et al.
Conflict and Health|April 24, 2024
The integration of ortho-plastic limb salvage teams in the humanitarian response to violence-related open tibial fractures: evaluating outcomes in the Gaza StripTheresa Farhat, Krystel Moussally, Hasan Nahouli, et al.
Journal for Immunotherapy of Cancer|March 25, 2021
Phase I study of a multitargeted recombinant Ad5 PSA/MUC-1/brachyury-based immunotherapy vaccine in patients with metastatic castration-resistant prostate cancer (mCRPC)Marijo Bilusic, Sheri McMahon, Ravi A Madan, et al.
Blood Cancer Journal|May 24, 2020
Combining gene expression profiling and machine learning to diagnose B-cell non-Hodgkin lymphomaVictor Bobée, Fanny Drieux, Vinciane Marchand, et al.
The Oncologist|December 27, 2019
Phase I Trial of a Modified Vaccinia Ankara Priming Vaccine Followed by a Fowlpox Virus Boosting Vaccine Modified to Express Brachyury and Costimulatory Molecules in Advanced Solid TumorsJulie M Collins, Renee N Donahue, Yo-Ting Tsai, et al.
Urology Annals|November 11, 2021
High rates of advanced prostate cancer in the Middle East: Analysis from a tertiary care centerMarilyne Daher, Talar Telvizian, Christelle Dagher, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|February 13, 2026
Comparative genomics and e-pharmacophore search to identify novel therapeutic targets in the druggable genome of MDR Providencia stuartiiAisha Siddiqa, Nimrah Muzaffar Sultan, Muhammad Irfan, et al.
Journal for Immunotherapy of Cancer|March 14, 2024
Efficacy, safety, and biomarker analyses of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with advanced non-small cell lung cancerArun Rajan, Houssein Abdul Sater, Osama Rahma, et al.
NPJ Breast Cancer|November 9, 2019
If we build it they will come: targeting the immune response to breast cancerMargaret E Gatti-Mays, Justin M Balko, Sofia R Gameiro, et al.
Pageof 44

Showing results (381-390 of 438) with videos related to

Sort By:
Pageof 44
Clinical Therapeutics|July 22, 2008
Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 microg QOD in patients with relapsing-remitting multiple sclerosis: a multicenter, randomized, double-blind, parallel-group pilot studyBarrie J Hurwitz, Douglas Jeffery, Barry Arnason, et al.
JCO Global Oncology|February 8, 2020
High-Cost Cancer Treatment Across Borders in Conflict Zones: Experience of Iraqi Patients in LebanonMac Skelton, Raafat Alameddine, Omran Saifi, et al.
Conflict and Health|April 24, 2024
The integration of ortho-plastic limb salvage teams in the humanitarian response to violence-related open tibial fractures: evaluating outcomes in the Gaza StripTheresa Farhat, Krystel Moussally, Hasan Nahouli, et al.
Journal for Immunotherapy of Cancer|March 25, 2021
Phase I study of a multitargeted recombinant Ad5 PSA/MUC-1/brachyury-based immunotherapy vaccine in patients with metastatic castration-resistant prostate cancer (mCRPC)Marijo Bilusic, Sheri McMahon, Ravi A Madan, et al.
Blood Cancer Journal|May 24, 2020
Combining gene expression profiling and machine learning to diagnose B-cell non-Hodgkin lymphomaVictor Bobée, Fanny Drieux, Vinciane Marchand, et al.
The Oncologist|December 27, 2019
Phase I Trial of a Modified Vaccinia Ankara Priming Vaccine Followed by a Fowlpox Virus Boosting Vaccine Modified to Express Brachyury and Costimulatory Molecules in Advanced Solid TumorsJulie M Collins, Renee N Donahue, Yo-Ting Tsai, et al.
Urology Annals|November 11, 2021
High rates of advanced prostate cancer in the Middle East: Analysis from a tertiary care centerMarilyne Daher, Talar Telvizian, Christelle Dagher, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|February 13, 2026
Comparative genomics and e-pharmacophore search to identify novel therapeutic targets in the druggable genome of MDR Providencia stuartiiAisha Siddiqa, Nimrah Muzaffar Sultan, Muhammad Irfan, et al.
Journal for Immunotherapy of Cancer|March 14, 2024
Efficacy, safety, and biomarker analyses of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with advanced non-small cell lung cancerArun Rajan, Houssein Abdul Sater, Osama Rahma, et al.
NPJ Breast Cancer|November 9, 2019
If we build it they will come: targeting the immune response to breast cancerMargaret E Gatti-Mays, Justin M Balko, Sofia R Gameiro, et al.
Pageof 44